Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration supports high selectivity and binding affinity to specific enzyme targets. Commonly employed in research settings to optimize drug candidates for improved metabolic stability and bioavailability. Also utilized in the preparation of compounds with potential neurological activity, including those under investigation for neurodegenerative diseases.